Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 18;17(1):144-156.
doi: 10.18240/ijo.2024.01.20. eCollection 2024.

Philippine retinoblastoma initiative multi-eye center study 2010-2020

Roland Joseph D Tan  1   2 , Gary John V Mercado  1   3 , Patricia E Cabrera  1   4 , Paulita Pamela P Astudillo  1   5 , Rolando Enrique D Domingo  1 , Josept Mari S Poblete  1 , Charmaine Grace M Cabebe  6 , Adriel Vincent R Te  6 , Melissa Anne S Gonzales  6 , Jocelyn G Sy  6 , Beltran Alexis A Aclan  7 , Jayson T So  7 , Fatima G Regala  7 , Kimberley Amanda K Comia  3 , Josemaria M Castro  3 , Mara Augustine S Galang  3 , Aldous Dominic C Cabanlas  8 , Benedicto Juan E Aguilar  8 , Gabrielle S Evangelista  8 , Jo Michael Maniwan  4 , Andrei P Martin  4 , Calvin Y Martinez  9 , John Alfred H Lim  9 , Rena Ivy Bascuna  10 , Rachel M Ng  10 , Kevin B Agsaoay  11 , Kris Zanna A Acluba-Arao  11 , Ellaine Rose V Apostol  7 , Beatriz M Prieto  7
Affiliations

Philippine retinoblastoma initiative multi-eye center study 2010-2020

Roland Joseph D Tan et al. Int J Ophthalmol. .

Abstract

Aim: To provide a comprehensive and more representative national data on the disease, especially on treatment options and outcomes, and to determine access of retinoblastoma patients from Luzon, Visayas and Mindanao to eye care, and determine if access is associated with delay in consultation, staging and outcomes.

Methods: Cohort study of retinoblastoma patients seen in eleven institutions located in the three major areas of the Philippines namely Luzon, Vizayas and Mindanao from 2010-2020.

Results: Totally 636 patients, involving 821 eyes, were included. Majority (57%) were from Luzon and were seen in institutions in Luzon (72%). Annually, 58±10 new cases were seen with 71% having unilateral disease. Median delay of consultation remained long at 9 (3, 17)mo, longest in patients with unilateral disease (P<0.02) and those from the Visayas (P<0.003). Based on the International Retinoblastoma Staging System, only 35% of patients had Stage 1 while 47% already had extraocular disease. Enucleation was the most common treatment received by 484 patients while intravenous chemotherapy was received by 469. There were 250 (39%) patients alive, 195 (31%) dead, 85 (13%) abandoned, 17 (3%) refused and 89 (14%) with no data.

Conclusion: This study presents the largest cohort of retinoblastoma patients in the Philippines in terms of patients' and participating institutions' number and geographical location and type of institution (private and public). It also presents more comprehensive data on the treatments used and outcomes (survival, globe salvage, and vision retention rates). Delay in consultation was still long among patients leading to advanced disease stage and lower survival rate. Despite increasing capacity to diagnose and manage retinoblastoma in the country, the delay of consultation remains long primarily due to accessibility issues to eye care institutions especially in the Visayas and financial concerns. The delay was still significant that overall survival rate remain low.

Keywords: Philippines; clinical profile; retinoblastoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Total number of new cases seen annually in the participating institutions from 2010-2020 based on eye involvement.
Figure 2
Figure 2. Distribution of length of delay in consultation based on eye involvement.
See this image and copyright information in PMC

References

    1. Domingo RED, Manganip LE, Castro RM. Tumors of the eye and ocular adnexa at the Philippine Eye Research Institute: a 10-year review. Clin Ophthalmol Auckl N Z. 2015;9:1239–1247. - PMC - PubMed
    1. Usmanov RH, Kivelä T. Predicted trends in the incidence of retinoblastoma in the asia-pacific region. Asia Pac J Ophthalmol (Phila) 2014;3(3):151–157. - PubMed
    1. Espiritu R, Jesus A, Valera EG, Mercado GV. Epidemiological pattern of retinoblastoma at the philippine general hospital. Philipp J Ophthalmol. 2004;29:136–139.
    1. Noguera SI, Mercado GV, Santiago D. Clinical epidemiology of retinoblastoma at the philippine general hospital: 1998-2008. Philipp J Ophthalmol. 2011;36:128–132.
    1. Global Retinoblastoma Study Group. Fabian ID, Abdallah E, et al. Global retinoblastoma presentation and analysis by national income level. JAMA Oncol. 2020;6(5):685–695. - PMC - PubMed

LinkOut - more resources